METHEMALBUMIN. I. APPEARANCE DURING ADMINISTRATION OF PAMAQUINE AND QUININE

^{Department of Medicine, New York University College of Medicine, New York City}

^{Research Service, Third [New York University] Medical Division, Goldwater Memorial Hospital, New York City}

^{Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University, Baltimore, Maryland}

Captain, MC, AUS.

This work was carried out under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and New York University.

The authors express their thanks to the Malaria Study Section of the National Institute of Health for editorial assistance and for arrangements in regard to the publication of this paper. They are also grateful to the Abbott Laboratories, E. I. du Pont de Nemours and Company, Inc., E. R. Squibb and Sons, Eli Lilly and Company, Sharp and Dohme, and Wyeth, Inc., for contributing toward the publication costs.

Find articles by Rosenfeld, M. in: JCI | PubMed | Google Scholar

^{Department of Medicine, New York University College of Medicine, New York City}

^{Research Service, Third [New York University] Medical Division, Goldwater Memorial Hospital, New York City}

^{Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University, Baltimore, Maryland}

Captain, MC, AUS.

This work was carried out under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and New York University.

The authors express their thanks to the Malaria Study Section of the National Institute of Health for editorial assistance and for arrangements in regard to the publication of this paper. They are also grateful to the Abbott Laboratories, E. I. du Pont de Nemours and Company, Inc., E. R. Squibb and Sons, Eli Lilly and Company, Sharp and Dohme, and Wyeth, Inc., for contributing toward the publication costs.

Find articles by Zubrod, C. in: JCI | PubMed | Google Scholar

^{Department of Medicine, New York University College of Medicine, New York City}

^{Research Service, Third [New York University] Medical Division, Goldwater Memorial Hospital, New York City}

^{Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University, Baltimore, Maryland}

Captain, MC, AUS.

This work was carried out under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and New York University.

The authors express their thanks to the Malaria Study Section of the National Institute of Health for editorial assistance and for arrangements in regard to the publication of this paper. They are also grateful to the Abbott Laboratories, E. I. du Pont de Nemours and Company, Inc., E. R. Squibb and Sons, Eli Lilly and Company, Sharp and Dohme, and Wyeth, Inc., for contributing toward the publication costs.

Find articles by Blake, W. in: JCI | PubMed | Google Scholar

^{Department of Medicine, New York University College of Medicine, New York City}

^{Research Service, Third [New York University] Medical Division, Goldwater Memorial Hospital, New York City}

^{Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University, Baltimore, Maryland}

Captain, MC, AUS.

This work was carried out under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and New York University.

The authors express their thanks to the Malaria Study Section of the National Institute of Health for editorial assistance and for arrangements in regard to the publication of this paper. They are also grateful to the Abbott Laboratories, E. I. du Pont de Nemours and Company, Inc., E. R. Squibb and Sons, Eli Lilly and Company, Sharp and Dohme, and Wyeth, Inc., for contributing toward the publication costs.

Find articles by Shannon, J. in: JCI | PubMed | Google Scholar